CN102325769A - 单卡波姆 - Google Patents

单卡波姆 Download PDF

Info

Publication number
CN102325769A
CN102325769A CN2009801569587A CN200980156958A CN102325769A CN 102325769 A CN102325769 A CN 102325769A CN 2009801569587 A CN2009801569587 A CN 2009801569587A CN 200980156958 A CN200980156958 A CN 200980156958A CN 102325769 A CN102325769 A CN 102325769A
Authority
CN
China
Prior art keywords
compound
pharmaceutically acceptable
amino
mmol
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2009801569587A
Other languages
English (en)
Chinese (zh)
Inventor
S.J.布里克纳
M.E.弗拉纳甘
M.S.拉尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of CN102325769A publication Critical patent/CN102325769A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CN2009801569587A 2008-12-19 2009-12-07 单卡波姆 Pending CN102325769A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13915908P 2008-12-19 2008-12-19
US61/139,159 2008-12-19
PCT/IB2009/055544 WO2010070523A1 (en) 2008-12-19 2009-12-07 Monocarbams

Publications (1)

Publication Number Publication Date
CN102325769A true CN102325769A (zh) 2012-01-18

Family

ID=41727494

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009801569587A Pending CN102325769A (zh) 2008-12-19 2009-12-07 单卡波姆

Country Status (15)

Country Link
US (2) US8252782B2 (cg-RX-API-DMAC7.html)
EP (1) EP2379546A1 (cg-RX-API-DMAC7.html)
JP (1) JP2012512863A (cg-RX-API-DMAC7.html)
KR (1) KR20110086742A (cg-RX-API-DMAC7.html)
CN (1) CN102325769A (cg-RX-API-DMAC7.html)
AR (1) AR074801A1 (cg-RX-API-DMAC7.html)
AU (1) AU2009329169B2 (cg-RX-API-DMAC7.html)
CA (1) CA2744756C (cg-RX-API-DMAC7.html)
IL (1) IL213216A0 (cg-RX-API-DMAC7.html)
MX (1) MX2011006541A (cg-RX-API-DMAC7.html)
PA (1) PA8855001A1 (cg-RX-API-DMAC7.html)
SG (1) SG171781A1 (cg-RX-API-DMAC7.html)
TW (1) TW201026696A (cg-RX-API-DMAC7.html)
UY (1) UY32336A (cg-RX-API-DMAC7.html)
WO (1) WO2010070523A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105481812A (zh) * 2015-11-30 2016-04-13 重庆天奕恒化科技有限公司 一种5-苄氧基-4-氧代-4h-吡喃-2-羧酸的制备方法

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2744756C (en) * 2008-12-19 2013-05-28 Pfizer Inc. Monocarbams and their use as antibacterial agent
JP5777725B2 (ja) 2010-11-29 2015-09-09 ファイザー・インク モノバクタム
UY34585A (es) * 2012-01-24 2013-09-02 Aicuris Gmbh & Co Kg Compuestos b-lactámicos sustituidos con amidina, su preparación y uso
AU2016327264B2 (en) 2015-09-23 2019-06-27 Novartis Ag Salts and solid forms of monobactam antibiotic
CN110312715A (zh) 2016-12-21 2019-10-08 艾库里斯有限及两合公司 用于抗生素耐药性细菌菌株感染的使用脒取代的β-内酰胺化合物和β-内酰胺酶抑制剂的组合疗法
ES2912656T3 (es) 2017-08-02 2022-05-26 Novartis Ag Proceso para preparar ácido 1-(((Z)-(1-(2-aminotiazol-4-il)-2-oxo-2-(((3S,4R)-2-oxo-4-((2-oxooxazolidin-3-il)metil)-1-sulfoacetidin-3-il)amino)etiliden)amino)oxi)ciclopropano carboxílico
US11034648B2 (en) 2017-08-23 2021-06-15 Helmholtz-Zentrum Für Cystobactamide derivatives
WO2019045085A1 (ja) 2017-08-31 2019-03-07 北興化学工業株式会社 1-(n,n-ジ置換カルバモイル)4-(置換スルホニル)トリアゾリン-5-オン誘導体、4-(n,n-ジ置換カルバモイル)1-(置換スルホニル)トリアゾリン-5-オン誘導体、およびそれらを有効成分として含有する除草剤
EP3747883A4 (en) 2018-01-29 2020-12-16 Medshine Discovery Inc. MONOCYCLIC B-LACTAM COMPOUND FOR TREATING BACTERIAL INFECTION
WO2020125670A1 (zh) 2018-12-18 2020-06-25 南京明德新药研发有限公司 单环β-内酰胺化合物在制药中的应用
US12491180B2 (en) 2019-12-19 2025-12-09 Shenzhen Optimum Biological Technology Co., Ltd Application of compound in treating pneumonia
JP2025513455A (ja) 2022-04-22 2025-04-24 バーテックス ファーマシューティカルズ インコーポレイテッド 疼痛の治療のためのヘテロアリール化合物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4587047A (en) * 1981-04-09 1986-05-06 E. R. Squibb & Sons, Inc. 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines
EP0281289A1 (en) * 1987-03-03 1988-09-07 The Upjohn Company Antibiotic sulfonylaminocarbonyl activated beta-lactams

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199981A (en) 1981-04-09 1985-08-16 Squibb & Sons Inc 2-oxo-1-(((substituted sulphonyl)amino)carbonyl)azetidines
US5006650A (en) * 1987-02-11 1991-04-09 The Upjohn Company Novel N-1 substituted beta-lactams as antibiotics
DE3864257D1 (de) 1987-02-11 1991-09-19 Upjohn Co Neue n-1 substituierte beta-lactame als antibiotika.
US5001235A (en) * 1987-02-27 1991-03-19 The Upjohn Company Antibiotic beta-lactams containing a pyridone carboxylic acid or acid derivative
US4762922A (en) * 1987-07-01 1988-08-09 Squibb Corporation 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines
US5015737A (en) * 1987-07-22 1991-05-14 The Upjohn Company Therapeutically useful beta-lactams
US4777252A (en) * 1987-08-13 1988-10-11 E. R. Squibb & Sons, Inc. 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines
US4889930A (en) 1987-12-21 1989-12-26 E. R. Squibb & Sons, Inc. Process for making 2-oxo-1-((substituted sulfonyl)amino)carbonzyl)azetidines and intermediates used therein
JPH01305081A (ja) 1988-04-04 1989-12-08 E R Squibb & Sons Inc 3―アシルアミノ―1―[[[(置換スルホニル)アミノ〕カルボニル〕アミノ〕―2―アゼチジノン類
EP0344707A3 (en) 1988-06-02 1990-04-18 E.R. Squibb & Sons, Inc. 2-Oxo-1-[[(substituted sulfonyl)-amino]carbonyl]-azetidine derivatives
US4959470A (en) * 1988-08-17 1990-09-25 E. R. Squibb & Sons, Inc. 2-oxo-[[(substituted sulfonyl)-amino]carbonyl]-azetidines
EP0436568A1 (en) 1988-09-27 1991-07-17 The Upjohn Company Dihydroxyaryl 4-substituted monocarbams as antibiotics
CA2210787A1 (en) 1997-07-17 1999-01-17 William R. Collier Self-contained work station
BRPI0809147A2 (pt) 2007-03-23 2014-08-26 Basilea Pharmaceutica Ag Medicamentos combinados para tratamento de infecções bacterianas
CA2744756C (en) * 2008-12-19 2013-05-28 Pfizer Inc. Monocarbams and their use as antibacterial agent

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4587047A (en) * 1981-04-09 1986-05-06 E. R. Squibb & Sons, Inc. 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines
EP0281289A1 (en) * 1987-03-03 1988-09-07 The Upjohn Company Antibiotic sulfonylaminocarbonyl activated beta-lactams

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GARY E.ZURENKO,ETC: "In vitro antibacterial activity and interactions with beta-lactamases and penicillin-binding proteins of the new monocarbam antibiotic U-78608.", 《ANTIMICROBIAL AGENTS AND CHEMOTHERAPY》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105481812A (zh) * 2015-11-30 2016-04-13 重庆天奕恒化科技有限公司 一种5-苄氧基-4-氧代-4h-吡喃-2-羧酸的制备方法
CN105481812B (zh) * 2015-11-30 2020-04-21 重庆天奕恒化科技有限公司 一种5-苄氧基-4-氧代-4h-吡喃-2-羧酸的制备方法

Also Published As

Publication number Publication date
CA2744756A1 (en) 2010-06-24
JP2012512863A (ja) 2012-06-07
TW201026696A (en) 2010-07-16
AU2009329169A1 (en) 2010-06-24
EP2379546A1 (en) 2011-10-26
US20100160281A1 (en) 2010-06-24
IL213216A0 (en) 2011-07-31
SG171781A1 (en) 2011-07-28
US20120289455A1 (en) 2012-11-15
WO2010070523A1 (en) 2010-06-24
KR20110086742A (ko) 2011-07-29
PA8855001A1 (es) 2010-07-27
US8252782B2 (en) 2012-08-28
MX2011006541A (es) 2011-07-20
AU2009329169B2 (en) 2012-06-28
UY32336A (es) 2010-07-30
AR074801A1 (es) 2011-02-16
CA2744756C (en) 2013-05-28
US8324198B1 (en) 2012-12-04

Similar Documents

Publication Publication Date Title
US8252782B2 (en) Monocarbams
JP2019532928A (ja) ベータラクタマーゼ阻害剤化合物
US11746116B2 (en) Antibiotic resistance breakers
JP2020536082A (ja) 細菌感染症を治療するためのクロマンモノバクタム化合物
JP4064462B2 (ja) セフェム化合物及び該化合物を含有する医薬
KR100203726B1 (ko) 티오알킬티오 세팔로스포린
JP2012511561A (ja) 細菌感染症に抗する2−(ピペリジン−1−イル)−4−ヘテロシクリル−チアゾール−5−カルボン酸誘導体
CN104011019B (zh) 吡咯衍生物
CN102648199A (zh) 哌啶化合物及其用途
JP7598594B2 (ja) オキソ置換化合物
JP2013177318A (ja) ジヒドロピリミジノン誘導体およびその医薬用途
US10919851B2 (en) 2-pyrrolidine phenylhydrazides antibacterial agents
US6987115B2 (en) Antibacterial compounds
CN117500802A (zh) Lactivicin化合物及其制备和作为抗菌剂的用途
CN102245603A (zh) 抗细菌感染的2-(哌啶-1-基)-4-唑基-噻唑-5-羧酸衍生物
US20210214359A1 (en) Compounds and Methods for Treating Bacterial Infections
WO1991006549A1 (fr) Composes de cephalosporine et fabrication de ceux_ci
JP3238209B2 (ja) チオメチルチオカルバセファロスポリン誘導体
JP7550421B2 (ja) オキソ置換化合物からなる医薬
HK1161238A (en) Monocarbams
CN107922436A (zh) 具有亚磺酰基或磺酰基的三环性化合物
WO2000034274A1 (en) Cyclohexylpiperidine derivatives
TW201930314A (zh) 具有亞磺醯基的三環性化合物及含有該三環性化合物的醫藥組成物
WO1988010263A1 (fr) Composes cristallins de cephalosporine, procede de preparation et produits intermediaires pour la preparation de ces composes
HK1163675A (en) 2-(piperidin-1-yl)-4-azolyl-thiazole-5-carboxylic acid derivatives against bacterial infections

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1161238

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120118

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1161238

Country of ref document: HK